Fast optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivo
In this webinar, Dr. Hailong He, Group leader at Technical University of Munich, presents his work on fast high-resolution optoacoustic imaging in human melanoma. He shows how 3D imaging of vascular characteristics in skin lesions could allow diagnostic insights not available by conventional visual inspection.
Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
In this webinar, Dr. Isabel Quiros Gonzalez, Head of the Histopathology Core at the University of Oviedo and previously with Cancer Research UK Cambridge Institute, outlines her work using MSOT (multispectral optoacoustic tomography) to assess response to a vascular-disruptive treatment in a preclinical breast cancer model.
Optoacoustic Imaging in Inflammatory Bowel Disease
Prof. Dr. med. Maximilian Waldner, Professor of Functional Imaging in Medicine at the University Hospital Erlangen
Novel genetically encoded contrast agents for preclinical optoacoustic imaging
Dr André Stiel, group leader at the Institute of Biological Medical Imaging at the Helmholtz Zentrum in Munich
Imaging Lymphatic Disorders with Optoacoustic Tomography
Guido Giacalone, M.D., Ph.D., Lymphatic Surgery in Mechelen, Belgium.
Multi-scale Clinical Optoacoustic Skin Imaging
Dr. Dinish U S, Group Leader, A*STAR Singapore Bioimaging Consortium (SBIC)
Dr. Chris Ho, Business Development Manager, A*STAR Singapore Bioimaging Consortium (SBIC)
Optoacoustic Imaging in Neuromuscular Disease
Dr. med. Ferdinand Knieling, University Hospital Erlangen Pediatrician
Optoacoustics and Optical: Complementary Modalities for Molecular Imaging
Judith Weber PhD, University of Cambridge
Alexa Hasenbach, University of Münster
Dr. Sheryl Roberts, Memorial Sloan Kettering
Clinical Vascular Imaging with Multispectral Optoacoustic Tomography (MSOT)
Dr. Max Masthoff MD, PhD, University Hospital Munster, Germany
MSOT and MRI – Complementary Modalities for Pre-clinical Imaging
Dr. Mark ‘Marty’ Pagel, Department of Cancer Systems Imaging, MD Anderson Cancer Center